Inactive Instrument
Guided Therapeutics Inc Share Price OTC Bulletin Board
Stocks
US40171F1057
Advanced Medical Equipment & Technology
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 07-14 | Guided Therapeutics, Inc. Announces New Agreement With Yuanshuo Medical Instruments Corporation | CI |
| 06-16 | Guided Therapeutics Files Premarket Approval Application Clinical Report with FDA | CI |
| Market Cap | 26.55M 23.27M 21.51M 19.78M 37.32M 2.56B 37.92M 257M 101M 1.25B 99.69M 97.51M 4.32B | P/E 2024 |
-3x | P/E 2025 | -12.7x |
|---|---|---|---|---|---|
| Enterprise Value | 29.42M 25.79M 23.84M 21.92M 41.37M 2.84B 42.03M 285M 112M 1.39B 110M 108M 4.78B | EV / Sales 2024 |
1,649x | EV / Sales 2025 | 64.4x |
| Free-Float |
63.48% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Faupel
CEO | Chief Executive Officer | 70 | 05/03/2023 |
| Chief Tech/Sci/R&D Officer | 70 | 01/12/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
John Imhoff
BRD | Director/Board Member | 76 | 09/04/2006 |
Richard Blumberg
BRD | Director/Board Member | 69 | 09/11/2016 |
Mark Faupel
BRD | Director/Board Member | 70 | 30/11/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.66% | -2.79% | +28.21% | -7.65% | 196B | ||
| -13.75% | -12.69% | -7.59% | -32.08% | 142B | ||
| +0.93% | -5.69% | -30.65% | +6.31% | 125B | ||
| -0.89% | +1.97% | -58.11% | -18.23% | 65.06B | ||
| -1.49% | -6.89% | +9.56% | -9.39% | 48.94B | ||
| -2.22% | +0.82% | -24.52% | -32.66% | 44.9B | ||
| +1.73% | -1.86% | +18.43% | +3.97% | 36.79B | ||
| +2.19% | -2.47% | +30.33% | +27.15% | 35.11B | ||
| -1.56% | +1.43% | -25.01% | -10.99% | 28.65B | ||
| Average | -1.79% | -3.21% | -6.59% | -8.17% | 80.27B | |
| Weighted average by Cap. | -3.14% | -2.97% | -3.86% | -10.52% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 7K 6.14K 5.67K 5.22K 9.84K 675K 10K 67.81K 26.58K 330K 26.28K 25.71K 1.14M | 767K 672K 621K 572K 1.08M 73.96M 1.1M 7.43M 2.91M 36.19M 2.88M 2.82M 125M |
| Net income | -2.42M -2.12M -1.96M -1.8M -3.4M -233M -3.45M -23.42M -9.18M -114M -9.08M -8.88M -393M | -3.2M -2.8M -2.59M -2.38M -4.49M -308M -4.57M -30.96M -12.14M -151M -12M -11.74M -520M |
| Net Debt | 1.77M 1.55M 1.43M 1.32M 2.49M 171M 2.53M 17.16M 6.73M 83.56M 6.65M 6.51M 288M | 2.88M 2.52M 2.33M 2.14M 4.04M 277M 4.11M 27.86M 10.92M 136M 10.8M 10.56M 468M |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
















